Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, March 25 - Friday, March 29 2024), and click each link to read and watch anything you may have missed.
1.) FDA grants FTD to nipocalimab for treating FNAIT
The FDA's Fast Track Designation for nipocalimab marks a significant step in addressing fetal neonatal alloimmune thrombocytopenia risk in pregnant patients, potentially revolutionizing treatment for this severe condition with unmet medical needs.
Click here for the full article.
2.) Sweating it out: Exercise in pregnancy
Explore the detriments of activity restriction, ACOG recommendations, and the benefits and safety precautions for exercising during pregnancy.
Click here for the full article.
3.) CDC estimates of maternal mortality found overestimated
Cande Ananth, PhD, MPH, discusses a study exposing discrepancies in CDC maternal mortality data, highlighting errors in tracking methods and persistent racial disparities in maternal mortality rates
Click here for the full article.
4.) PCOS status linked to menopause age onset
A recent regression model analysis unveils a 5% prolonged period to menopause in women with polycystic ovary syndrome, prompting further investigation into the condition's impact on reproductive health and the need for diverse longitudinal studies.
Click here for the full article.
5.) Enhancing tubal sterilization decision-making: MyDecision aid study
Discover how a web-based decision aid significantly enhances the quality of tubal sterilization decision-making, offering crucial insights for marginalized populations, as revealed in a recent study.
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
Impact of antiepileptic medications and sex hormones on maternal and child outcomes in epilepsy
May 16th 2024Paula Emanuela Voinescu, MD, PhD, director of the Women's Epilepsy Program at Brigham and Women's Hospital, talked about the influence of sex hormones on maternal outcomes in pregnant women with epilepsy treated with antiseizure medication.
Read More
S4E3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents
March 2nd 2022In this episode of Pap Talk, Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.
Listen
Echogenic Mass identified as key predictor for retained products of conception
May 13th 2024Discover how recent findings highlight the significance of echogenic masses in accurately diagnosing post-pregnancy complications, shedding light on effective management strategies and reducing the need for invasive interventions.
Read More
Mail-order dispensing of mifepristone for medication abortion found effective
May 13th 2024A recent study revealed that mail-order pharmacy dispensing of mifepristone for medication abortion proves effective and satisfactory, highlighting a potential avenue for expanding access to reproductive healthcare.
Read More